Save Time, Save Resources, Save Lives.

About Us

ExcitePCRTM has developed proprietary technologies that enable highly accurate, rapid, point-of-need molecular diagnostics. These technologies are being prepped for commercialization within the FireflyDXTM family of pathogen detection systems: small, all-in-one labs that can detect any bio-threat or other pathogen anytime, anywhere, providing accurate results within 30 minutes without additional laboratory equipment.

These first-in-class technologies were designed and developed by a strong scientific team and through work with several strategic partners, including the U.S. Department of Homeland Security (DHS) and ENSCO, NASA, and the U.S. Special Operations Command (USSOC).

ExcitePCR is targeting worldwide molecular diagnostic applications where Point-of-Need / Point-of-Care (PON / POC) biological detection is becoming a requirement for identifying biohazards and infectious diseases, ensuring food safety, and for agricultural and environmental testing.

Company Background

2004 MicroFludic Systems, the predecessor company to ExcitePCR and a leader in biological testing and sample prep applications, was the only company to successfully complete a seven-year, $35 million development contract with the DHS to develop an automated pathogen detection system (M-BAND), developmental efforts that laid the foundation for FireflyDX.

2011 MicroFluidic Systems was acquired by PositiveID Corporation to accelerate development of a proprietary molecular diagnostic instrumentation (FireflyDX).

2014 FireflyDX is selected by DHS for the SenseNet biological monitoring program.

2016 Initial in-lab FireflyDX breadboard prototypes achieved lab-quality sample preparation and detection standards for a variety of pathogens.

2017 ExcitePCR is formed as a wholly owned subsidiary of PositiveID to provide greater flexibility for strategic partnership and/or financing opportunities.